This study is looking at a new drug, DISC-0974, to help people with two blood problems: myelofibrosis and myelodysplastic syndrome, both of which can cause anemia (low red blood cells). The study aims to see if the drug is safe and effective in treating anemia caused by these conditions.

Participants must be 18 or older, have anemia, and meet specific health criteria. For example, they should not have had certain treatments recently, like blood transfusions or specific medications, and should not have other health issues that could interfere with the study. Women of childbearing age must use effective birth control.

• The study includes several visits over time, but exact details on how many are not provided here.
• Participants must stop certain medications 28 days before starting the study.
• There might be risks involved, but details are not specified here.

Anyone interested should talk to their doctor to see if they qualify and to understand potential benefits and risks.